Specially Appointed Research Fellow
National Center for Global Health and Medicine, Japan
Disclosure(s): No financial relationships to disclose
I am Nobumasa Okumura, MD, on a fellowship of Disease Control and Preventino Center in National Center for Global Health and Medicine.
2007 - 2013 Nagoya University, School of Medicine
Junior Residency
Apr 2013 - Mar 2015, Anjo Kosei Hospital, Japan
Senior Residency
Apr 2015 - Mar 2017, Anjo Kosei Hospital, Japan
Trainee of Respiratory Medicine
Apr 2017 - Mar 2021, Anjo Kosei Hospital, Japan
Fellowship of Infectious Diseases
Apr 2021 - present, National Center for Global Health and Medicine, Japan
Board Certified Member of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Respiratory Society
Successful treatment of aortic valve endocarditis caused by Enterococcus casseliflavus: a case report. BMC Infect Dis 2021; 21: 447.
Varicella pneumonia in an immunocompetent, unvaccinated man: A case report. Int J Infect Dis Regions 2022; 2: 60-2
The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics. Glob Health Med 2022
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan. J Infect Chemother. 2022; 28(9): 1340-1343
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination. J Infect Chemother 2022; 28: 1704-1706
Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis. BMC Infect Dis 2023; 23: 307
“Take” after LC16m8 for mpox. Int J Infect Dis 2023; 134: 290-1
Relapse of toxocariasis after completion of four-week treatment with albendazole. J Infect Chemother 2024 Jan 17:S1341-321X(24)00020-5.